{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T01:56:27Z","timestamp":1696298187790},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1007\/s11239-005-1452-0","type":"journal-article","created":{"date-parts":[[2005,8,4]],"date-time":"2005-08-04T17:41:00Z","timestamp":1123177260000},"page":"163-172","source":"Crossref","is-referenced-by-count":20,"title":["The Impact of Patient Self-Testing of Prothrombin Time for Managing Anticoagulation: Rationale and Design of VA Cooperative Study #481\u2014The Home INR Study (THINRS)"],"prefix":"10.1007","volume":"19","author":[{"given":"David B.","family":"Matchar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan K.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert G.","family":"Edson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip W.","family":"Lavori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack E.","family":"Ansell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Ezekowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick","family":"Rickles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lou","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Boardman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciaran","family":"Phibbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan D.","family":"Fihn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia E.","family":"Vertrees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rowena","family":"Dolor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1452_CR1","doi-asserted-by":"crossref","first-page":"445S","DOI":"10.1378\/chest.114.5_Supplement.445S","volume":"114","author":"J Hirsh","year":"1998","unstructured":"Hirsh J, Dalen JE, Anderson D, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1998;114:445S\u2013469S.","journal-title":"Chest"},{"key":"1452_CR2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0002-9343(02)01131-2","volume":"113","author":"DB Matchar","year":"2002","unstructured":"Matchar DB, Samsa GP, Cohen SJ, Oddone EZ, Jurgelski AE. Improving the quality of anticoagulation of patients with atrial fibrillation in managed care organizations: Results of managing anticoagulation services trial. Am J Med 2002;113:42\u201351.","journal-title":"Am J Med"},{"key":"1452_CR3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.7326\/0003-4819-111-9-730","volume":"111","author":"RH White","year":"1989","unstructured":"White RH, MuCurdy SA, von Marensdorff H, Woodruff DE, Leftfoff L. Home prothrombin time monitoring after the initiation of warfarin therapy: A randomized, prospective study. Ann Intern Med 1989;111: 730\u2013737.","journal-title":"Ann Intern Med"},{"key":"1452_CR4","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1001\/archinte.1995.00430200066010","volume":"155","author":"JE Ansell","year":"1995","unstructured":"Ansell JE, Patel N, Ostrovsky D, Nozzolillo E, Peterson M, Fish L. Long-term patient self-management of oral anticoagulation. Arch Intern Med 1995;155:2185\u20132189.","journal-title":"Arch Intern Med"},{"key":"1452_CR5","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1023\/A:1018712520472","volume":"9","author":"H Koertke","year":"2000","unstructured":"Koertke H, Minami K, Bairaktaris A, Wagner O, Koerfer R. INR self-management following mechanical heart valve replacement. J Throm THrombolysis 2000;9:S31\u2013S45.","journal-title":"J Throm THrombolysis"},{"issue":"Suppl 1","key":"1452_CR6","first-page":"66","volume":"12","author":"RJ Beyth","year":"1997","unstructured":"Beyth RJ, Landefeld CS. Prevention of major bleeding in older patients treated with warfarin: results of a randomized trial. (abstract) J Gen Intern Med 1997;12 (Suppl 1):66.","journal-title":"(abstract) J Gen Intern Med"},{"key":"1452_CR7","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S1010-7940(97)01204-9","volume":"11","author":"JM Hasenkam","year":"1997","unstructured":"Hasenkam JM, Kimose HH, Knudsen L, et al. Self management of oral anticoagulant therapy after heart valve replacement. Eur J Cardiothorac Surg 1997;11:935\u2013942.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1452_CR8","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1023\/A:1013228718768","volume":"5","author":"D Horstkotte","year":"1998","unstructured":"Horstkotte D, Piper C, Wiemer M. Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. J Thromb Thrombolysis 1998;5:S19\u2013S24.","journal-title":"J Thromb Thrombolysis"},{"key":"1452_CR9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/jama.281.2.145","volume":"281","author":"PT Sawicki","year":"1999","unstructured":"Sawicki PT. A structured teaching and self-management program for patients receiving oral anticoagulation: A randomized controlled trial. JAMA 1999;281:145\u2013150.","journal-title":"JAMA"},{"key":"1452_CR10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1023\/A:1018778914477","volume":"9","author":"GP Samsa","year":"2000","unstructured":"Samsa, GP, Matchar DB. Relationship between test frequency and outcomes of anticoagulation: A literature review and commentary with implications for the design of randomized trials of patient self-management. J Thromb Thrombolysis 2000;9:283\u2013292.","journal-title":"J Thromb Thrombolysis"},{"key":"1452_CR11","unstructured":"Centers for Medicare & Medicaid Services (CMS). Coverage and Billing for Home Prothrombin Time International Normalized Ratio (INR) Monitoring for Anticoagulation Management. Program Memorandum: CMS-Pub. 60AB; Transmittal AB-03-089. June 20, 2003."},{"key":"1452_CR12","unstructured":"ITC. Available at: http:\/\/www.itcmed.com. (accessed December 3, 2004)."},{"key":"1452_CR13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0735-1097(91)90585-W","volume":"18","author":"SJ Connolly","year":"1991","unstructured":"Connolly SJ, Laupacis A, Gent M, et al. for the CAFA Study Coinvestigators. Canadian Atrial Fibrillation Anticoagulation (CAFA) study. J Am Coll Cardiol 1991;18:349\u2013355.","journal-title":"J Am Coll Cardiol"},{"key":"1452_CR14","doi-asserted-by":"crossref","unstructured":"Ezekowitz MD, Bridgers SL, James KE, et al. for the Veterans affairs stroke prevention in nonrheumatic atrial fibrillation investigators. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med 1992;327:1406\u20131412. Erratum in: N Engl J Med 1993 Jan 14;328:148.","DOI":"10.1056\/NEJM199211123272002"},{"key":"1452_CR15","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJM199011293232201","volume":"323","author":"Boston area anticoagulation trial for atrial fibrillation investigators","year":"1990","unstructured":"Boston area anticoagulation trial for atrial fibrillation investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990;323:1505\u20131511.","journal-title":"N Engl J Med"},{"key":"1452_CR16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.CIR.84.2.527","volume":"84","author":"Stroke prevention in atrial fibrillation investigators","year":"1991","unstructured":"Stroke prevention in atrial fibrillation investigators. stroke prevention in atrial fibrillation study: Final results. Circulation 1991;84:527\u2013539.","journal-title":"Circulation"},{"key":"1452_CR17","doi-asserted-by":"crossref","unstructured":"Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449\u20131457. Erratum in: Arch Intern Med 1994 Oct 10;154(19):2254.","DOI":"10.1001\/archinte.1994.00420130036007"},{"key":"1452_CR18","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0140-6736(93)92358-Z","volume":"342","author":"European Atrial Fibrillation Trial Study Group","year":"1993","unstructured":"European Atrial Fibrillation Trial Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke. Lancet 1993;342:1255\u20131262","journal-title":"Lancet"},{"key":"1452_CR19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199507063330103","volume":"333","author":"SC Cannegieter","year":"1995","unstructured":"Cannegieter SC, Rosendaal FR, Wintzen AR, van der Meer FJ, Vandenbroucke JP, Briet E. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995;333:11\u201317.","journal-title":"N Engl J Med"},{"key":"1452_CR20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0003-4975(01)02656-X","volume":"72","author":"H Kortke","year":"2001","unstructured":"Kortke H, Korfer R. International normalized ratio self-management after mechanical heart valve replacement: Is an early start advantageous? Ann Thorac Surg 2001;72:44\u201348.","journal-title":"Ann Thorac Surg"},{"key":"1452_CR21","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJM199903253401201","volume":"340","author":"C Kearon","year":"1999","unstructured":"Kearon C, Gent M, Hirsh J, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999;340:901\u2013907","journal-title":"N Engl J Med"},{"key":"1452_CR22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199702063360601","volume":"336","author":"S Schulman","year":"1997","unstructured":"Schulman S, Granqvist S, Holmstrom M, et al., and The Duration of Anticoagulation Study Group. The Duration of oral anticoagulant therapy after a second episode of venous thromboembolism. N Engl J Med 1997;336:393\u2013398.","journal-title":"N Engl J Med"},{"key":"1452_CR23","doi-asserted-by":"crossref","unstructured":"Freedman LS. Tables of the number of patients required in clinical trials using the logrank test. Stat Med 1982;1:121\u2013129. Erratum in Control Clin Trials 1994;15:326.","DOI":"10.1002\/sim.4780010204"},{"key":"1452_CR24","unstructured":"Harrell FE. Jr. CPOWER, Hmisc library, Splus 2000, Mathsoft, June, 1999."},{"key":"1452_CR25","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0197-2456(93)90031-8","volume":"14","author":"B Peterson","year":"1993","unstructured":"Peterson B, George SL. Sample size requirements and length of study for testing interaction in a 2 \u00d7 k factorial design when time-to-failure is the outcome. Control Clin Trials 1993;14:511\u2013522.","journal-title":"Control Clin Trials"},{"key":"1452_CR26","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2307\/2531201","volume":"42","author":"JM Lachin","year":"1986","unstructured":"Lachin JM, Foulkes MA. Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification. Biometrics 1986;42:507\u2013519.","journal-title":"Biometrics"},{"key":"1452_CR27","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2307\/2531021","volume":"39","author":"DA Schoenfeld","year":"1983","unstructured":"Schoenfeld DA. Sample-size formula for the proportional-hazards regression model. Biometrics 1983;39:499\u2013503.","journal-title":"Biometrics"},{"key":"1452_CR28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2307\/2529712","volume":"31","author":"SJ Pocock","year":"1975","unstructured":"Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975;31:103\u2013115.","journal-title":"Biometrics"},{"key":"1452_CR29","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0197-2456(85)90120-5","volume":"6","author":"N Birkett","year":"1985","unstructured":"Birkett N. Adaptive allocation in randomized controlled trials. Control Clin Trials 1985;6:146\u2013155.","journal-title":"Control Clin Trials"},{"key":"1452_CR30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/biomet\/58.3.403","volume":"58","author":"B Efron","year":"1971","unstructured":"Efron B. Forcing a sequential experiment to be balanced. Biometrika 1971;58:403\u2013417.","journal-title":"Biometrika"},{"key":"1452_CR31","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0038-1651587","volume":"69","author":"FR Rosendaal","year":"1993","unstructured":"Rosendaal FR, Cannegieter SC, van der Meer FJM, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993;69:236\u2013239.","journal-title":"Thromb Haemost"},{"key":"1452_CR32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1477-7525-2-22","volume":"2","author":"GP Samsa","year":"2004","unstructured":"Samsa GP, Matchar DB, Dolor RJ, et al. A new instrument for measuring anticoagulation-related quality of life: Development and preliminary validation. Health Qual Life Outcomes 2004;2:22.","journal-title":"Health Qual Life Outcomes"},{"key":"1452_CR33","doi-asserted-by":"crossref","first-page":"704","DOI":"10.7326\/0003-4819-127-8_Part_2-199710151-00054","volume":"127","author":"DB Matchar","year":"1997","unstructured":"Matchar DB, Samsa GP, Matthews JR, et al. The stroke prevention policy model (SPPM): Linking evidence and clinical decisions. Ann Intern Med 1997;127:704\u2013711.","journal-title":"Ann Intern Med"},{"issue":"19","key":"1452_CR34","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.1995.00430190097013","volume":"155","author":"PD Stein","year":"1995","unstructured":"Stein PD, Hull RD, Pineo G. Strategy that includes serial noninvasive leg tests for diagnosis of thromboembolic disease in patients with suspected acute pulmonary embolism based on data from PIOPED. Prospective investigation of pulmonary embolism diagnosis. Arch Intern Med 1995;155(19):2101\u20132104.","journal-title":"Arch Intern Med"},{"issue":"3","key":"1452_CR35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s002590050228","volume":"25","author":"HW Gray","year":"1998","unstructured":"Gray HW, Bessent RG. Pulmonary embolism exclusion: A practical approach to low probability using the PIOPED data. Prospective investigation of pulmonary embolism diagnosis. Eur J Nucl Med 1998;25(3):271\u2013276.","journal-title":"Eur J Nucl Med"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-005-1452-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-005-1452-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-005-1452-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T07:01:29Z","timestamp":1559372489000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-005-1452-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["1452"],"URL":"https:\/\/doi.org\/10.1007\/s11239-005-1452-0","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}